Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Benitec
354
Benitec
Technology
Biotechnology
Health Care
Medical
Diagnostics
Health Diagnostics
Silencing Genes for Life: Benitec is developing novel treatments for chronic & life-threatening conditions via ddRNAi. Publicly Listed NASDAQ:BNTC and ASX:BLT
Suggest edits
Type
B2c
Raised
$5.5M
Follow us
Companies in the same industry
CereScan
Diagnostic Hybrids
PrimeGen Biotech
Celator Pharmaceuticals
Biosceptre
MBio Diagnostics
Bikanta
EndoChoice
TauRx Pharmaceuticals
Oxford Immunotec
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$5,450,000
Post-IPO equity - 2017
NantCapital
Team Size
1–10
Employees
I work here
Location
Australia
Headquarters
Explore Australia
$5,450,000
Post-IPO equity
GEN
$4.1M Nant Investment in Benitec Supports Joint Antisense RNA Program for HNSCC Genetic Engineering & Biotechnology News...
